Budget impact and transferability of cost–effectiveness of DPYD testing in metastatic breast cancer in three health systems (Personalized Medicine, 2023)

(untitled) - Koleva-Kolarova, R; Vellekoop, H; Huygens, S; Versteegh, M; Mölken, MR-V; Szilberhorn, L; Zelei, T; Nagy, B; Wordsworth, S; Tsiachristas, A